Joshua Raskin First question is just are the new members coming in at higher-than-expected MLRs even for first year members? Or is it just a mix because they're mostly agents. And then if you could just refresh the MLR trends for members that are in fully capitated arrangements versus those that are in sort of fee-for-service providers. And has that delta changed much in the last year? Josh, for your first question, we are seeing that new members are running higher MLRs than you would expected that we would ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...

Company Participants Bruce Broussard - President and CEO Conference Call Participants A.J. Rice - Credit Suisse Nathan Rich - Goldman Sachs Steve Valiquette - Barclays Gary Taylor - Cowen David Windley - Jefferies Operator I would now like to hand the conference over to Lisa Stoner, Vice President of Investor Relations. Please go ahead. Thank you and good morning. In a moment, Bruce Broussard, HumanaÂ's President and Chief Executive Officer; and Susan Diamond, Chief Financial Officer, will discuss our secon ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or o ...

We firmly believe the Medicare Advantage program will remain a compelling value proposition for seniors and expect Humana will be well positioned to remain an industry leader in 2024 and beyond. We will provide more specific thoughts on 2024 in the coming months post completion of the competitive bidding process. Thank you, Bruce, and good morning, everyone. With that in mind, revenue for the quarter exceeded initial expectations, driven by the better-than-expected membership growth. Our Medicaid business p ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 1-5975 HUMANA INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation of organization) ...

Humana Inc. (NYSE:HUM) Q4 2022 Earnings Conference Call February 1, 2023 9:00 AM ET Lisa Stoner – Vice President-Investor Relations Conference Call Participants Company Participants Susan Diamond – Chief Financial Officer A.J. Rice – Credit Suisse Kevin Fischbeck – Bank of America Scott Fidel – Stephens Nathan Rich – Goldman Sachs Michael Ha – Morgan Stanley George Hill – Deutsche Bank Operator I would now like to hand the conference over to your speaker today, Lisa Stoner, VP of Investor Relations. Please ...

Humana Inc. (NYSE:HUM) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET Company Participants Lisa Stoner – Vice President-Investor Relations Bruce Broussard – President and Chief Executive Officer Susan Diamond – Chief Financial Officer Conference Call Participants Stephen Baxter – Wells Fargo Kevin Fischbeck – Bank of America Justin Lake – Wolfe Research Nathan Rich – Goldman Sachs Gary Taylor – Cowen Scott Fidel – Stephens George Hill – Deutsche Bank Josh Raskin – Nephron Research A.J. Rice – ...

Humana Inc. (NYSE:HUM) Q2 2022 Earnings Conference Call July 27, 2022 9:00 AM ET Company Participants Lisa Stoner - Vice President, Investor Relations Bruce Broussard - President and Chief Executive Officer Susan Diamond - Chief Financial Officer Joe Ventura - Chief Legal Officer Conference Call Participants Justin Lake - Wolfe Research Matt Borsch - BMO Capital Markets Kevin Fischbeck - Bank of America A.J. Rice - Credit Suisse Nathan Rich - Goldman Sachs Joshua Raskin - Nephron Research Ricky Goldwasser - ...